Jose Manuel G. P.
- Country
- Spain
- Department
- Cardiology
Research Overview
- A Phase 3, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Levosimendan in Patients with Pulmonary Hypertension and HFpEF
- Phase IIb Randomized Double‑Blind Placebo‑Controlled Study of Eplontersen Plus ALXN2220 Versus Eplontersen + Placebo in Adults with Transthyretin‑Mediated Amyloid Cardiomyopathy
- Evaluation of High-Dose Pulse Intravenous Methylprednisolone Sodium Succinate in Patients with Complicated Fulminant Acute Myocarditis
Data & Insights
Has run more than one trial at 338 of 854 partner sites.
Specializations
Cardiomyopathy Research
This investigator specializes in treating various forms of cardiomyopathy, with particular emphasis on transthyretin amyloid cardiomyopathy (ATTR-CM) and hypertrophic cardiomyopathy. Their research extends to innovative therapeutic approaches for managing these complex cardiac conditions.
- ATTR Amyloidosis Management
- Obstructive Hypertrophic Cardiomyopathy Treatment
- Novel Therapeutic Interventions
Cardiovascular Disease Prevention
The investigator focuses on preventive cardiology, particularly in atherosclerotic cardiovascular disease (ASCVD) and heart failure prevention. Their work includes evaluation of innovative treatments for reducing cardiovascular events and mortality.
- Cardiovascular Risk Reduction
- Heart Failure Prevention Strategies
- Cardiovascular Event Management
Cardiac Inflammation
Research interests include the treatment of acute myocarditis and severe cardiac inflammation. The investigator explores therapeutic approaches including corticosteroid therapy for inflammatory cardiac conditions.
- Myocarditis Treatment
- Inflammatory Cardiac Disease Management
- Advanced Therapeutic Protocols
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.